Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rangering i aksjer #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Aksjekurs
$0.5099
Sist synkronisert: 2024-10-15
Markedsverdi
$7.60M
Endring (1 dag)
2.02%
Endring (1 år)
0.00%
Land
US
Handel Anew Medical, Inc. (WENA)

Kategori

EPS for Anew Medical, Inc. (WENA)
EPS per June 2024 TTM: $0.00
Ifølge de siste økonomiske rapportene og aksjekursen til Anew Medical, Inc. er selskapets nåværende EPS (TTM) $0.00. Ved slutten av 2022 hadde selskapet en EPS på $0.08, en økning sammenlignet med EPS-en i 2021 som var $-0.09.
EPS-historikk for Anew Medical, Inc. fra 2021 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) 0.00 -102.64%
2023 $0.14 69.29%
2022 $0.08 -196.73%
2021 $-0.09 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -468,208.11%
US
$27.74 -749,829.73%
NL
- -
CH
- -
KR
$13.70 -370,372.97%
BE